Screener
Ocular Therapeutix OCUL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Deferred revenue | 14,000 | 14,000 |
| Notes payable, net | 72,062 | 71,336 |
| Other non-current liabilities | 909 | 887 |
| Total liabilities | 150,955 | 153,747 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 400,000,000 and 400,000,000 shares authorized and 218,896,915 and 215,927,600 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 22 | 22 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's total liabilities?
- Ocular Therapeutix (OCUL) reported total liabilities of $150.96M in Q1 2026.
- How has Ocular Therapeutix's total liabilities changed year-over-year?
- Ocular Therapeutix's total liabilities increased by 7.8% year-over-year, from $139.99M to $150.96M.
- What is the long-term trend for Ocular Therapeutix's total liabilities?
- Over 5 years (2020 to 2025), Ocular Therapeutix's total liabilities has grown at a -3.7% compound annual growth rate (CAGR), from $185.77M to $153.75M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Ocular Therapeutix's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude